Dean A. Post

Senior Director, Scientific Programs, American Association for Cancer Research - Tweets are mine, not those of the AACR

[Zymeworks Inc. @ZymeworksInc]

https://t.co/eTNYsSuez3 #AACR24

[Roy Herbst @DrRoyHerbst]

Honored to host today’s press conference at #AACR24 with exciting developments in screening, glioblastoma treatment, and vaccine therapies. @AACR @YaleCancer @SmilowCancer @YaleMed @YNHH

[Lillian Siu @lillian_siu]

Full house in pre @aacr inaugural AACR Oncology Industry Partnering Event - exciting pipelines and drug development paths 🔥🔥🔥

[Winn Awards @WinnAwards]

The @WinnAwards Career Development Award is open for applications! The 2-year program provides training and support for early-stage investigator physicians to advance diversity in clinical trials. Details at https://t.co/QG4E1UlAGz. 𝐀𝐩𝐩𝐥𝐲 𝐛𝐲 𝐌𝐚𝐲 𝟏𝟑, 𝟐𝟎𝟐𝟒.

[Mithat Gönen @gonen_mithat]

Come work with the best @MSKBiostats

[Winn Awards @WinnAwards]

Apply now to join the next cohort of Winn CDA scholars https://t.co/GuUGg1gena. Register for an upcoming info session to learn more: https://t.co/gO5vGI1jwc
#DiversityinMedicine #RepresentationMatters #DiversityinClinicalTrials
#UnderrepresentedinMedicine

[Ben Creelan, MD MS @BenCreelan]

As we wrap up #Targets23, kudos to everyone for an inspiring session. I can't wait to see what therapy may be in clinic next year! @EORTC

[Elizabeth McKenna @ElizSMcKenna]

What an honor to be included in this group!

[EORTC @EORTC]

Calling all at the #Targets23 meeting in Boston, MA. Visit us at stand 501 and get the latest info on the next edition #ENASymp24 (Barcelona 23-25 October 2024) and our other events and projects.

@AACR @theNCI #EndCancer

[AACR @AACR]

The Journey of Antibody Drug Conjugate Development: AACR President-Elect Patricia M. LoRusso joined conference cochair @VriesElisabeth to moderate this #Targets23 plenary session, featuring Raffaele Colombo, Anthony W. Tolcher, and Paolo Tarantino. @raffcolo @PTarantinoMD

[Clinical Cancer Research @CCR_AACR]

Attending #Targets23?
If you’d like to talk about your research or have any questions about publishing in Clinical Cancer Research, please reach out to Assistant Editor, @DrRachelHodge, during or after the meeting.
@AACR

[Molecular Cancer Therapeutics @MCT_AACR]

Attending #Targets23?
If you’d like to talk about your research or have any questions about publishing in Molecular Cancer Therapeutics, please reach out to Assistant Editor, Danielle Large, PhD, during or after the meeting.
@AACR

[AACR @AACR]

Attending #Targets23 in Boston, Oct 11-15? Visit our booth to learn about AACR initiatives that will improve patient care—including a live demo of how AACR Project GENIE® powers precision medicine to accelerate drug discovery and improve clinical trial design.
#AACRGENIE

[Prof FTO 🇳🇬🇺🇸 @DrOdedina]

Congratulations to my brother ⁦@phd_yates ,⁩ inaugural recipient of The John R. Lewis Professorship in Pathology at ⁦@JohnsHopkins⁩ School of Medicine. What a well deserved honor and so emotional. We are so proud of you!!! God is good!

[Dr. Rob Winn @DrRobWinn]

I thank Del. @CarrieCoyner, @YMCARichmond, Chester United Methodist Church and @ChesterfieldVa Supervisor Jim Ingle for connecting @VCUMassey with the Greenleigh community today. Through District Walks, we talk with people where they live to learn how we can meet their needs.

[AACR @AACR]

Submit an abstract by July 10 for the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (October 11-15, Boston), chaired by Timothy A. Yap, @TimGreten, and @VriesElisabeth. Learn more:
https://t.co/cwaZfRYTeT
#Targets23

[AACR @AACR]

Submit an abstract by July 10 for the San Antonio Breast Cancer Symposium, December 5-9, 2023. Learn more:
https://t.co/EesFsGRbMe
#SABCS23

[Melissa B Davis, PhD @MeliD32]

We got a spotlight in the Cancer Discovery Global Oncology collection! I'm so proud to be part of 2 in the collection!! @phd_yates @MartiniRachel @DocBJenkins @LANewmanMD @WCMEnglanderIPM @MSMEDU

[Tanya Bondar @_TanyaBondar_]

Blood Cancer Discovery's very first Impact Factor is released today. Huge thanks to our authors, reviewers, readers, academic board, Editors-In-Chief, in-house team of @BCD_AACR and our sister journals for reaching this mark!

[Matteo Lambertini, MD PhD @matteolambe]

Grateful and honored to be here 6 years after my participation as a fellow…what a fantastic event and unique atmosphere!!!! 💪🥰🔝🤩
@OncoAlert @myESMO @EORTC @AACR